3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Recruiting
1
Completed
1
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
3
Lymphoid
3
Other
2
Head & Neck
2
Gastrointestinal
2
CNS
2
Tumor-Agnostic
1
NET
1
Gynecologic
1
Endocrine
1
Conditions
Stomatitis
2
Mucositis
2
Mouth Neoplasms
2
Head and Neck Neoplasms
2
Carcinoma, Squamous Cell
1
Interventions
Exercise
27
Metformin
24
Methods
14
Radiotherapy
13
Early Intervention, Educational
13
Educational Status
12
Counseling
12
Surveys and Questionnaires
10
Standard of Care
10
Nutrition Assessment
9
Resistance Training
8
Diet Therapy
8
Cisplatin
8
naloxegol
7
Tirzepatide
7
Diet
7
alvimopan
6
Psychiatric Rehabilitation
6
Fibroblast Growth Factor 7
6
Caloric Restriction
6
Radiation
5
Low-Level Light Therapy
5
Liraglutide
5
Injections
5
Exenatide
5
Dexamethasone
5
Cryotherapy
5
semaglutide
4
angiotensin I (1-7)
4
Vitamin D
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
RRx-001
×
Other
×
Clear all
NCT05966194
2024-11-15
KEVLARx
EpicentRx, Inc.
Phase 2
Recruiting
216 enrolled
NCT03515538
2024-11-04
PREVLAR
EpicentRx, Inc.
Phase 2
Completed
53 enrolled
15 charts